BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Staging
6 results:

  • 1. Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.
    Tejedor-Tejada J; Gómez-Díez C; Robles Gaitero S; Villar Caamaño A; Hermida Pérez B; Olmos JM; Álvarez Álvarez A; Tojo González R
    Rev Esp Enferm Dig; 2022 Aug; 114(8):509-510. PubMed ID: 35297265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Toward an Optimized staging System for pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.
    Bertsimas D; Margonis GA; Huang Y; Andreatos N; Wiberg H; Ma Y; Mcintyre C; Pulvirenti A; Wagner D; van Dam JL; Gavazzi F; Buettner S; Imai K; Stasinos G; He J; Kamphues C; Beyer K; Seeliger H; Weiss MJ; Kreis M; Cameron JL; Wei AC; Kornprat P; Baba H; Koerkamp BG; Zerbi A; D'Angelica M; Wolfgang CL
    JCO Clin Cancer Inform; 2021 Dec; 5():1220-1231. PubMed ID: 34936469
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index.
    Yang F; Wu W; Wang X; Zhang Q; Bao Y; Zhou Z; Jin C; Ji Y; Windsor JA; Lou W; Fu D
    Ann Surg Oncol; 2021 Jan; 28(1):550-559. PubMed ID: 32424583
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]    [Full Text] [Related]  

  • 5. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
    Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
    Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Concomitant radiochemotherapy in unresectable carcinoma of the exocrine pancreas: cost-effectiveness analysis.
    Cellini N; Costamagna G; Morganti AG; Valentini V; Macchia G; Mutignani M; Pandolfi M; Trodella L
    Rays; 1999; 24(3):447-52. PubMed ID: 10605305
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.